Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.56 - $3.25 $20,138 - $41,954
-12,909 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.61 - $5.2 $20,783 - $67,126
12,909 New
12,909 $41,000
Q4 2021

Feb 14, 2022

SELL
$2.87 - $6.29 $44,241 - $96,960
-15,415 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$4.91 - $9.07 $75,687 - $139,814
15,415 New
15,415 $96,000

Others Institutions Holding BCEL

About Atreca, Inc.


  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.